Document Detail


Molecular analysis of the intestinal microflora in IBD.
MedLine Citation:
PMID:  19079221     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nucleic acid-based (molecular) analytical methods have utility in discriminating between bowel microbiota of altered compositions. This has been demonstrated in studies involving both experimental animals and humans with inflammation of the bowel. Although alterations in the composition of the microbiota can be demonstrated, future studies need to provide functional links between the candidate proinflammatory agents and disease processes.
Authors:
G W Tannock
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Mucosal immunology     Volume:  1 Suppl 1     ISSN:  1935-3456     ISO Abbreviation:  -     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-12-16     Completed Date:  2009-02-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101299742     Medline TA:  Mucosal Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S15-8     Citation Subset:  IM    
Affiliation:
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. gerald.tannock@stonebow.otago.ac.nz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenomatous Polyposis Coli / drug therapy,  microbiology
Animals
Anti-Bacterial Agents / therapeutic use
Biopsy
Colitis, Ulcerative / diagnosis,  microbiology,  surgery
Humans
Inflammatory Bowel Diseases / diagnosis,  drug therapy,  metabolism*,  microbiology*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Innate immune recognition of the indigenous microbial flora.
Next Document:  Identification of the predominant antigenic epitopes in intestinal flora in IBD.